ProQR Therapeutics N.V.

NasdaqCM:PRQR Stock Report

Market Cap: US$239.9m

ProQR Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:PRQR Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
09 Jul 26BuyUS$261,000Daniel de BoerIndividual150,000US$1.74
07 Jul 26BuyUS$238,500Daniel de BoerIndividual150,000US$1.59
26 Jun 26BuyUS$231,000Bart FiliusIndividual150,000US$1.54
05 Feb 26BuyUS$2,154,236Van Herk Investments B.V.Company1,054,560US$2.04
29 Sep 25BuyUS$2,300,634Van Herk Investments B.V.Company1,055,000US$2.18
03 Sep 25BuyUS$2,401,687Van Herk Investments B.V.Company1,072,500US$2.24
21 Jul 25BuyUS$1,319,201Van Herk Investments B.V.Company700,195US$1.88

Insider Trading Volume

Insider Buying: PRQR insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PRQR?
Owner TypeNumber of SharesOwnership Percentage
Private Companies340,3740.241%
Individual Insiders2,591,5431.84%
VC/PE Firms15,384,25010.9%
Public Companies16,895,10012%
Institutions35,379,52725.1%
General Public70,530,68250%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 34%.

Top Shareholders

Top 25 shareholders own 47.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12%
Eli Lilly and Company
16,895,100US$28.7m0%no data
10.9%
Van Herk Investments B.V.
15,384,250US$26.2m0%5.01%
4.43%
Adage Capital Management, L.P.
6,253,467US$10.6m0%0.01%
3.87%
Privium Fund Management BV
5,467,149US$9.3m0%1.18%
2.35%
Aberdeen Group Plc
3,316,965US$5.6m12.4%no data
1.74%
Affinity Asset Advisors, LLC
2,454,278US$4.2m0%0.21%
1.39%
Sio Capital Management, LLC
1,954,715US$3.3m-9.68%0.39%
1.11%
Dafna Capital Management, LLC
1,567,561US$2.7m0%0.51%
1.11%
Kynam Capital Management, LP
1,566,317US$2.7m0%0.16%
1.06%
Ikarian Capital, LLC
1,492,229US$2.5m0%0.37%
0.92%
Morgan Stanley
1,299,775US$2.2m-4.89%no data
0.88%
L1 Group Limited
1,235,514US$2.1m0%0.19%
0.65%
Two Sigma Investments, LP
918,857US$1.6m9.47%no data
0.58%
Gerard Platenburg
824,388US$1.4m0%no data
0.54%
Point72 Asset Management, L.P.
755,842US$1.3m-7.1%no data
0.51%
Domenico Valerio
725,692US$1.2m72.5%no data
0.5%
Citadel Advisors LLC
703,323US$1.2m20.6%no data
0.44%
Nomura Investment Management Business Trust
620,000US$1.1m0%no data
0.43%
Walleye Capital LLC
607,529US$1.0m2.66%no data
0.43%
M28 Capital Management LP
599,793US$1.0m-41.2%2.24%
0.39%
Raymond James Financial, Inc.
546,079US$928.3k59.3%no data
0.33%
Rene Beukema
460,000US$782.0k0%no data
0.3%
Monaco Asset Management S.A.M.
418,803US$712.0k-2.33%0.19%
0.25%
Boothbay Fund Management, LLC
355,283US$604.0k0%0.01%
0.22%
UBS Asset Management AG
305,264US$518.9k-61.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/19 10:55
End of Day Share Price 2026/07/17 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ProQR Therapeutics N.V. is covered by 19 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Douglas BuchananBrean Capital Historical (Janney Montgomery)
Eliana MerleCantor Fitzgerald & Co.
Steven SeedhouseCantor Fitzgerald & Co.